Table 2. Proportion (%) of children with HIV RNA load ≥50 copies/mL at 0, 14, and 28 days after interrupting a nevirapine- or efavirenz-containing HAART regimen with use of either a staggered stop (SS) or replacement stop (RS) strategy.
Nevirapine group |
Efavirenz group |
|||||
---|---|---|---|---|---|---|
Treatment interruption strategy | Day 0 | Day 14 | Day 28 | Day 0 | Day 14 | Day 28 |
SS and RS | 3/20 (15) | 6/16 (38) | 19/20 (95) | 3/14 (21) | 2/12 (17) | 12/13 (92) |
SS | 2/11 (18) | 3/9 (33) | 11/11 (100) | 2/10 (20) | 2/7 (29) | 8/8 (100) |
RS | 1/9 (11) | 3/7 (43) | 8/9 (89) | 1/4 (25) | 0/5 (0) | 4/5 (80) |